Summary
-
1)
In isolated perfused hearts of reserpine (R)-and pargyline (P)-pretreated rabbits (i.e. RP-hearts) initial rates of intracellular uptake of 14C-tyramine and of 3H-amphetamine were measured as described by Graefe et al. (1978). The uptake of 14C-tyramine, but not that of 3H-amphetamine was inhibited by cocaine.
-
2)
Saturation kinetics of the intracellular uptake of 14C-tyramine revealed a non-saturable (diffusional) and a saturable (carrier-mediated) component of uptake.
-
3)
After 30 min of perfusion with 14C-tyramine the accumulated 14C-radioactivity in RP-hearts consisted of unchanged tyramine (about 60%), octopamine (about 30%) and deaminated metabolites (about 10%). In contrast, 14C-octopamine was the main radioactive substance when the perfusion with 14C-tyramine was followed by 100 min of wash-out.
-
4)
IC50-Values of tyramine, amphetamine, amantadine and nomifensine for inhibition of neuronal uptake of 3H-noradrenaline were determined in RPU-hearts (i.e. in RP-hearts whose COMT was inhibited by U-0521).
-
5)
About equieffective concentrations (with respect to inhibition of 3H-noradrenaline uptake) of tyramine, amphetamine, amantadine and noradrenaline (i.e. of substrates of the neuronal amine carrier) caused a pronounced (and comparable) release of 3H-noradrenaline from RPU-hearts, whereas cocaine and nomifensine (i.e. uptake inhibitors) caused only a very small release. Low sodium caused a release comparable to that induced by substrates of the amine carrier.
-
6)
Increasing concentrations of tyramine (0.2–24 μmol/l) caused mobilization of 3H-noradrenaline from a small “bound fraction” and partial mobilization from a large compartment which was characterized by a rate constant for efflux of about 0.014 min−1 (compartment I). The peak-value of the tyramine-induced efflux of 3H-noradrenaline exhibited saturability with increasing concentrations of tyramine. Half-maximal release was observed at a tyramine concentration which corresponded to a) the IC50-value for inhibition of uptake of 3H-noradrenaline and b) the K m of the saturable component of uptake of 14C-tyramine.
-
7)
That part of neuronally accumulated 3H-noradrenaline (mainly in compartment I) which was not further mobilized by high concentrations of tyramine was also hardly mobilized by veratridine (in the absence of Ca2+). However, in the presence of Ca2+, veratridine as well as nicotine induced a release of this “tyramine-resistant” 3H-noradrenaline.
-
8)
It is concluded that in RPU-hearts the distribution of 3H-noradrenaline within the partially “tyramine-resistant” compartment I and within the “bound fraction” might represent 3H-noradrenaline “trapped” within the acid interior of “reserpinized” vesicles and within a small population of intact storage vesicles, respectively. The fast release of 3H-noradrenaline (from RPU-hearts) by tyramine, noradrenaline, amphetamine and amantadine might be caused by facilitation of the outward transport of axoplasmic noradrenaline; the extend of facilitation may be directly connected to the velocity of uptake of these substrates by the amine carrier.
Similar content being viewed by others
References
Andén NE, Corrodi H, Ettles M, Gustafson E, Persson H (1964) Selective uptake of some catecholamines by the isolated heart and its inhibition by cocaine and phenoxybenzamine. Acta Pharmacol Toxicol 21:247–258
Bönisch H (1981) Evidence for a cocaine-sensitive and sodium-dependent uptake of amphetamine. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 316:R54
Bönisch H, Graefe KH, Keller B (1980) Reserpine-like, tetrodotoxin (TTX)-resistant effect of veratridine in the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 311:R61
Brandao F, Rodrigues-Pereira E, Guilherme Monteiro J, Davidson R (1981) A kinetic study of the release of noradrenaline by tyramine. Naunyn-Schmiedeberg's Arch Pharmacol 318:83–87
Carlsson A, Waldeck B (1966) Effects of amphetamine, tyramine, and protryptyline on reserpine-resistant amine-concentrating mechanisms of adrenergic nerves. J Pharm Pharmacol 18:252–253
Carlsson A, Fuxe K, Hamberger B, Lindqvist M (1966) Biochemical and histochemical studies on the effect of imipramine-like drugs and (+)amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand 67:481–492
Enna SJ, Shore PA (1974) On the nature of the adrenergic neurone extragranular amine binding site. J Neural Transmiss 35:125–135
Evoniuk G, Slotkin TA (1981) pH Dependence of (3H)norepinephrine uptake into catecholamine storage vesicles isolated from rat brain, heart and adrenal medulla. Biochem Pharmacol 30:2872–2873
Farnebo LO (1971) Effects of reserpine on release of 3H-noradrenaline, 3H-dopamine, and 3H-metaraminol from field stimulated rat iris. Biochem Pharmacol 20:2715–2726
Famebo LO, Fuxe K, Goldstein M, Hamberger B, Ungerstedt U (1971) Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's disease. Eur J Pharmacol 16:27–38
Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusional model. J Pharmacol Exp Ther 208:203–209
Giachetti A, Hollenbeck RA (1976) Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of adrenergic neurone blocking agents. Br J Pharmacol 58:497–504
Giles RE, Miller JW (1967) Studies on the potentiation of the inotropic actions of certain catecholamines by U-0521 (3′,4′-dihydroxymethyl propiophenone). J Pharmacol Exp Ther 157:55–61
Golko DS, Paton DM (1976) Characteristics of accumulation of ephedrine in rabbit atria. Can J Physiol Pharmacol 54:93–100
Graefe KH (1981) The disposition of 3H-(−)noradrenaline in the perfused cat and rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 318:71–82
Graefe KH, Trendelenburg U (1974) The effect of hydrocortisone on the sensitivity of the isolated nictitating membrane to catecholamines: relationship to extraneuronal uptake and metabolism. Naunyn-Schmiedeberg's Arch Pharmacol 286:7–48
Graefe KH, Stefano FJE, Langer SZ (1973) Preferential metabolism of 3H-(−)norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160
Graefe KH, Stefano FJE, Langer SZ (1977) Stereoselectivity in the metabolism of 3H-noradrenaline during uptake into and efflux from the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 299:225–238
Graefe KH, Bönisch H, Keller B (1978) Saturation of the adrenergic neurone uptake system in the perfused rabbit heart. A new method for determination of initial rates of amine uptake. Naunyn-Schmiedeberg's Arch Pharmacol 302:263–273
Henseling M, Eckert E, Trendelenburg U (1976) The distribution of 3H-(±)-noradrenaline in rabbit aortic strips after inhibition of the noradrenaline-metabolizing enzymes. Naunyn-Schmiedeberg's Arch Pharmacol 292:205–217
Holbach HJ, Lindmar R, Löffelholz K (1977) DMPP and the adrenergic nerve terminal: mechanisms of noradrenaline release from vesicular and extravesicular compartments. Naunyn-Schmiedeberg's Arch Pharmacol 300:131–138
Holz RW (1978) Evidence that catecholamine transport into chromaffine vesicles is coupled to vesicle membrane potential. Proc Natl Acad Sci USA 75:5190–5194
Johnson RG, Scarpa A (1976) Internal pH of isolated chromaffin vesicles. J Biol Chem 251:2189–2191
Lindmar R, Löffelholz K (1974) Neuronal and extraneuronal uptake and efflux of catecholamines in the isolated rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 284:63–92
Lundberg P, Stitzel R (1967) Uptake of biogenic amines by two different mechanisms present in adrenergic granules. Br J Pharmacol 29:342–349
Lundberg P, Waldeck B (1971) On the mechanism of amphetamine induced release of reserpine-resistant 3H-noradrenaline and 3H-methylnoradrenaline. Acta Pharmacol Toxicol 30:339–347
Mack F, Bönisch H (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn-Schmiedeberg's Arch Pharmacol 310:1–9
Mekanontchai R, Trendelenburg U (1979) The neuronal and extra-neuronal distribution of 3H(−)noradrenaline in the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 308:199–210
Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol 49:614–627
Paton DM (1976) Characteristics of efflux of noradrenaline from adrenergic neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven Press, New York, pp 155–174
Pereira ER, Bönisch H (1978) The uptake of tyramine and the release by tyramine of extravesicular noradrenaline in the isolated perfused hearts of reserpine pretreated rabbits. In: Proceedings of the 3rd Meeting on Adrenergic Mechanisms, Porto, pp 70–71
Raiteri M, Bertolini A, Angelini F, Levi G (1975) d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189–195
Ross SB, Kelder D (1976) Effect of veratridine on the fluxes of 3H-noradrenaline and 3H-bretylium in the rat vas deferens in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 295:183–189
Ross SB, Kelder D (1977) Evoked efflux of 3H-bretylium by sympathomimetic amines from the rat vas deferens in vitro. Acta Pharmacol Toxicol 40:87–96
Ross SB, Renyi AL (1966) Uptake of tritiated tyramine and (+)amphetamine by mouse heart slices. J Pharm Pharmacol 18:756–757
Ross SB, Renyi AL (1978) Effect of (+)amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart. Acta Pharmacol Toxicol 42:328–336
Rutledge CO, Vollmer S (1979) Evidence for carrier mediated efflux of noradrenaline displaced by amphetamine. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines; Basic and clinical frontiers, vol 1. Pergamon Press, New York, pp 304–306
Sammet S, Graefe KH (1979) Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for cotransport. Naunyn-Schmiedeberg's Arch Pharmacol 309:99–107
Snedecor GW, Cochran WG (1976) Statistical methods (6th edtion). Iowa State University Press, Ames
Steinberg MI, Smith CB (1971) Uptake, retention and metabolism of 3H-tyramine in rat atria. J Pharmacol Exp Ther 176:139–148
Thoenen H, Hürlimann A, Haefely W (1968) Mechanism of amphetamine accumulation in the isolated perfused heart of the rat. J Pharm Pharmacol 20:1–11
Trendelenburg U (1978) Release induced by phenethylamines. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon Press, New York: 333–354
Trendelenburg U, Bönisch H, Graefe KH, Henseling M (1980) The rate constants for the efflux of metabolites of catecholamines and phenethylamines. Pharmacol Rev. 31:179–203
Van Orden LD, Schaefer JM, Antonaccio MJ, Smith CB (1974) Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea pig atria. J. Pharmacol Exp Ther 188:668–675
Wilkinson GN (1961) Statistical estimation in enzyme kinetics. Biochem. J 80:324–332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bönisch, H., Rodrigues-Pereira, E. Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts. Naunyn-Schmiedeberg's Arch. Pharmacol. 323, 233–244 (1983). https://doi.org/10.1007/BF00497669
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00497669